Table 1.
Patient characteristics and treatment modality of 276 patient with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Variables | Number [Total 276] | Percentage |
---|---|---|
Patient characteristics | ||
Site of primary lesion | ||
Hypopharynx | 135 | 49% |
Oropharynx | 141 | 51% |
Age | ||
>65 years old | 128 | 46% |
≤65 years old | 148 | 54% |
Gender | ||
Male | 253 | 92% |
Female | 23 | 8% |
Karnofsky Performance Scale | ||
≥90 | 205 | 74% |
<90 | 71 | 26% |
Current smoker | ||
Yes | 119 | 43% |
No | 157 | 57% |
Smoking history | ||
≥10 packs year | 208 | 75% |
<10 packs year | 68 | 25% |
Clinical T stage | ||
4 | 43 | 16% |
3 | 79 | 29% |
2 | 113 | 41% |
1 | 41 | 15% |
Clinical N stage | ||
3 | 23 | 8% |
2 | 126 | 46% |
1 | 41 | 15% |
0 | 86 | 31% |
Treatment modality | ||
Radiation method | ||
IMRT | 53 | 19% |
Conventional 3D-CRT | 223 | 81% |
Radiation fractionation | ||
Once daily | 244 | 88% |
Twice daily | 8 | 3% |
Concomitant boost | 24 | 9% |
Neck dissection | ||
Yes | 41 | 15% |
No | 235 | 85% |
Concurrent chemotherapy | ||
Yes | 112 | 41% |
DCF | 36 | 13% |
CF | 43 | 16% |
Platinum alone | 20 | 7% |
Other regimens | 13 | 5% |
No | 164 | 59% |
Induction chemotherapy | ||
Yes | 93 | 34% |
DCF | 80 | 29% |
CF | 11 | 4% |
Other regimens | 3 | 1% |
No | 182 | 66% |